September 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study introduces the MHS Hair Restoration Protocol, a systems-biology model targeting hair follicle health through the gut-microbiome-endocannabinoidome axis and innovative topical treatments, emphasizing a holistic approach to pattern hair loss.
September 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This research introduces the MHS Hair Restoration Protocol, which is a comprehensive approach aimed at restoring the hair follicle environment by modulating the gut-microbiome-endocannabinoidome axis and incorporating specific dietary and topical strategies, rather than focusing only on short-term hair count improvements.
September 2026 in “Advanced Materials Technologies” In a mouse model study, researchers developed a methacrylated hyaluronic acid-based hydrogel microneedle patch co-loaded with finasteride and a carbon monoxide-releasing molecule for androgenetic alopecia, which showed better hair regrowth and safety compared to traditional treatments, offering an innovative approach with minimized systemic side effects.
September 2026 in “Wound Repair and Regeneration” This systematic review suggests that stem cell-based therapies may offer potential benefits for healing pure venous ulcers, but findings are preliminary due to small sample sizes and varied interventions.
August 2026 in “Anais Brasileiros de Dermatologia” This systematic review found that while hair transplantation in patients with lichen planopilaris may serve as a cosmetic option, there is a notable decline in graft survival rates after two years, and the data currently lacks prospective studies for stronger evidence.
August 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study developed and evaluated a coconut oil-based polyherbal hair oil using various medicinal plants, finding it exhibited satisfactory physicochemical properties and stability, making it a promising hair care formulation, though further biological evaluation is needed to confirm therapeutic benefits.
August 2026 in “Zenodo (CERN European Organization for Nuclear Research)” The researchers reported that a coconut oil-based polyherbal hair oil developed using traditional medicinal plants demonstrated satisfactory physicochemical properties, including stability and pH suitability for scalp application, though further biological evaluation is needed to confirm therapeutic effects.
August 2026 in “Cosmoderma” This review identifies sebaceous gland disorders as key indicators of hormonal imbalances, detailing how various hormones affect sebaceous function, and emphasizes a multidisciplinary approach to improve diagnosis and management by integrating endocrine, metabolic, and dermatologic insights.
August 2026 in “Acta Dermato Venereologica” This study found that women with central centrifugal cicatricial alopecia had a substantial prevalence of systemic comorbidities, including strong associations with dyslipidemia, uterine leiomyomas, and anxiety disorders.
August 2026 in “International Journal For Multidisciplinary Research” This case report suggests that a comprehensive phase-wise Unani therapeutic approach may improve multiple clinical, hormonal, and metabolic outcomes in a young woman with Polyendocrine Metabolic Ovarian Syndrome.
August 2026 in “Cell Biomaterials” D-chiral biomaterial scaffolds enhance tissue and hair regeneration by activating the body's immune system.
In this case report, a 48-year-old woman with kerion celsi showed improvement with a regimen including antifungal, bacterial, and adjunctive treatments, though the specific role of mesenchymal stromal cell secretome could not be isolated from the other therapies.
July 2026 in “Regenerative medicine reports .” This study concluded that nanoparticle-based delivery systems may significantly enhance wound healing and tissue regeneration in third-degree burns, though challenges like nanoparticle variability and cytotoxicity remain.
July 2026 in “The Professional Medical Journal” This study conducted in Peshawar, Pakistan, observed that individuals with Long COVID frequently reported systemic symptoms such as hair loss, headache, and fatigue, along with oral issues like loss of taste and dry mouth, highlighting the importance of incorporating oral symptom assessments in post-COVID care.
July 2026 in “Applied Sciences” This review suggests that 308 nm excimer therapy may offer a well-tolerated non-pharmacologic option for alopecia areata, with more limited evidence for its effectiveness in lichen planopilaris and frontal fibrosing alopecia.
July 2026 in “Journal of Investigative Dermatology” This retrospective cohort study found that individuals with alopecia totalis or universalis have a higher prevalence of systemic autoimmune diseases, particularly endocrine diseases and inflammatory bowel disease, compared to those with patchy alopecia areata.
July 2026 in “Journal of the Kenya National Commission for UNESCO” In this study, commercial synthetic braiding hair samples from Kenya were analyzed, revealing that while no Ammonium Thioglycolate was detected, significant formaldehyde contamination was present, with varying concentrations throughout the hair strands, potentially impacting consumer safety.
July 2026 in “Annals of Medicine and Surgery” This study found that arthritis and mucocutaneous features are common at early stages of SLE, while sicca, vasculitis, and hematologic manifestations tend to increase as the disease progresses.
July 2026 in “Mendeley Data” Higher doses of oral minoxidil can help hair growth but may have safety risks.
July 2026 in “Mendeley Data” Higher doses of oral minoxidil can help hair growth but may have safety risks.
July 2026 in “Anais Brasileiros de Dermatologia” This research observed that nanocarrier formulations of minoxidil improve follicular targeting and hair-growth outcomes in experimental settings, but their clinical efficacy and safety for treating androgenetic alopecia in patients remain unverified, necessitating further randomized clinical trials.
June 2026 in “Pediatric Drugs” This study analyzed systemic treatment patterns in 262 French children with severe alopecia areata, finding that while intravenous corticosteroids were most commonly used initially, treatment effectiveness appeared limited with frequent relapses and a need for prolonged therapy, but without serious adverse events.
June 2026 in “Scientific Reports” This study found that systemic testosterone exposure in transgender individuals with XX genotype alters skin biology, increasing androgen and estrogen receptor-positive cells, collagen density, and fibronectin expression while reducing immune cells, which could affect surgical outcomes by promoting a male skin phenotype.
In this study, patient-reported flare symptoms after COVID-19 vaccination in individuals with systemic lupus erythematosus were generally mild, with 17% experiencing flares mostly characterized by joint pain and fatigue; vaccine type did not affect flare incidence.
June 2026 in “Research Square” This study evaluated an herbal emulgel formulation containing extracts from Wedelia chinensis and Cassytha filiformis for hair growth promotion in rats, finding that the combined formulation significantly increased hair growth compared to both individual extracts and the control group.
This study developed a natural herbal hair dye powder using Eclipta prostrata, Nigella sativa, and Aloe Vera, which offers safe and environmentally friendly hair coloring while avoiding harmful effects associated with conventional dyes.
May 2026 in “Skin Appendage Disorders” This study determined that low-level light therapy and fractional lasers are effective and safe treatments for androgenetic alopecia, especially when combined with other agents like minoxidil, PRP, or growth factors.
May 2026 in “Global Translational Medicine” This study found that ethanol extract of Syzygium aromaticum (clove) leaves significantly improved lipid profiles and increased body weight in testosterone-induced benign prostatic hyperplasia rats, suggesting potential anti-hyperlipidemic effects and modulation of body weight through metabolic activity.
May 2026 in “International Journal of Current Pharmaceutical Review and Research” This article discusses the causes of polycystic ovary syndrome, including environmental pollutants, genetics, and oxidative stress, and explains how these factors contribute to symptoms like irregular menstrual cycles and obesity without reporting new clinical results.
May 2026 in “Journal of Clinical Medicine” In this study, post-COVID-19 patients showed substantial multisystem symptoms six to eight months after infection compared to controls, with a higher burden in non-respiratory areas like fatigue and neurocognitive issues, despite respiratory symptoms largely resolving.